Article Versions Notes

Zhang C, Liu Y, Guo H, Peng Y, Huang L, Lu S, Wang Z. Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma. Biomedicines. 2025; 13(7):1598. https://doi.org/10.3390/biomedicines13071598

Zhang, Chenglin, Yanyan Liu, Haoran Guo, Ying Peng, Lei Huang, Shuangshuang Lu, and Zhimin Wang. 2025. "Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma" Biomedicines 13, no. 7: 1598. https://doi.org/10.3390/biomedicines13071598

Zhang, C., Liu, Y., Guo, H., Peng, Y., Huang, L., Lu, S., & Wang, Z. (2025). Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma. Biomedicines, 13(7), 1598. https://doi.org/10.3390/biomedicines13071598